This page shows you your search results in order of date. This is page number 12.

Order by Relevance | Date

Total 17126 results found since Jan 2013.

Commonly prescribed medications associated with alopecia
Source: Journal of the American Academy of Dermatology - August 24, 2023 Category: Dermatology Authors: Chaker Ben Salem, Mohamed Denguezli Source Type: research

Response to “Lack of association between comorbidities and central centrifugal cicatricial alopecia: a retrospective cohort study of 153 patients” By Jafari et al.
Source: Journal of the American Academy of Dermatology - August 24, 2023 Category: Dermatology Authors: Bonnie W. Leung, Donald A. Glass, Katherine Ayoade Source Type: research

Alopecia Study Analyzes Impact of Baricitinib Uptitration Alopecia Study Analyzes Impact of Baricitinib Uptitration
Findings were drawn from the ongoing phase 3 randomized clinical trials BRAVE-AA1 and BRAVE-AA2.Medscape Medical News
Source: Medscape FamilyMedicine Headlines - August 23, 2023 Category: Primary Care Tags: Dermatology News Source Type: news

The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area
ConclusionTo the best of our knowledge, this is the first study investigating the effectiveness and safety of sonidegib in the management of BCC localized at the periocular region. Even if limited, our study suggests this drug as a valuable and safe option in periocular BCC management.
Source: Dermatology and Therapy - August 23, 2023 Category: Dermatology Source Type: research

Trichoscopic Features of Syphilitic Alopecia and Alopecia Areata: A Comparative Study
CONCLUSION: Despite the presence of several similar trichoscopic features between SA and AA, trichoscopy can aid in distinguishing between the two diseases. Exclamation mark hairs are the only trichoscopic feature that can be used to differentiate patients with clinically suspicious SA from those with AA.PMID:37608922 | PMC:PMC10441631 | DOI:10.2147/CCID.S424054
Source: Clinical, Cosmetic and Investigational Dermatology - August 23, 2023 Category: Dermatology Authors: Kasama Tejapira Nawara Sakpuwadol Cherrin Pomsoong Yanisa Ratanapokasatit Poonkiat Suchonwanit Source Type: research

Combination of adipose-derived stem cell conditioned media and minoxidil for hair regrowth in male androgenetic alopecia: a randomized, double-blind clinical trial
CONCLUSION: Combination of ADSC-CM and minoxidil could be a potential agent for hair regrowth. Follow-up research with extensive populations, longer duration, and different study design may be required to confirm the exact mechanisms of ADSC-CM on hair growth.TRIAL REGISTRATION: Clinicaltrials.gov, NCT05296863. Registered 25 March 2022-Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT05296863 .PMID:37605227 | DOI:10.1186/s13287-023-03440-2
Source: Cell Research - August 22, 2023 Category: Cytology Authors: Lili Legiawati Lis Surachmiati Suseno Irma Bernadette S Sitohang Shannaz Nadia Yusharyahya Jeanne Adiwinata Pawitan Isabella Kurnia Liem Trie Kurniawati Athaya Ardelia Kanya Paramastri Source Type: research

GSE223884 VDR is an essential regulatory factor in the stage of hair follicle regression through the progression of cell death
Contributors : Yudai Joko ; Shun SawatsubashiSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe Vitamin D receptor (VDR) is essential for hair follicle homeostasis as its deficiency leads to hair loss. However, the mechanism behind this relationship is unknown. Our research shows that in VDR knockout mice, the hair cycle is halted during the catagen stage, preceding alopecia. Additionally, in VDR knockout hair follicles, epithelial strands that normally regress during the catagen phase persist as "surviving epithelial strands." Analysis using single cell RNA sequencing suggests these...
Source: GEO: Gene Expression Omnibus - August 22, 2023 Category: Genetics & Stem Cells Tags: Expression profiling by high throughput sequencing Mus musculus Source Type: research

Alopecia Areata: Current Treatments and New Directions
This article will review the efficacy, safety, and tolerability of current treatments for alopecia areata, and will provide an overview of the emerging therapies that are leading the revolution in the management of this challenging disease.
Source: American Journal of Clinical Dermatology - August 22, 2023 Category: Dermatology Source Type: research

Psychosocial impact of androgenetic alopecia on men: A systematic review and meta-analysis
.
Source: Psychology, Health and Medicine - August 22, 2023 Category: International Medicine & Public Health Authors: Hannah Frith Glen S. Jankowski Source Type: research

LB1777 A novel ex vivo model of human hair follicle immune privilege collapse reveals the potential of farudodstat, a DHODH inhibitor, as a therapeutic for alopecia areata treatment
In this study, we investigated whether farudodstat, a DHODH inhibitor, could be beneficial for the treatment of AA by means of an innovative model in which healthy human microdissected HFs were stimulated with anti-CD3/CD28 antibodies to promote intra- and peri-follicul ar T-cell activation via the T-cell receptor (TCR).
Source: Journal of Investigative Dermatology - August 21, 2023 Category: Dermatology Authors: T. Rouill é, S. Barbosa, A. Steinhoff, I. Piccini, J. Edelkamp, F. Cevikbas, M. Bertolini Source Type: research

LB1773 Dutasteride in the treatment of frontal fibrosing alopecia: Systematic review and meta-analysis
Background: Frontal fibrosing alopecia (FFA) is a type of scarring alopecia characterized by fronto-temporo-parietal hairline recession which is mostly seen in postmenopausal women. Although no proven treatment for FFA exists, dutasteride has been suggested as a potential treatment option. Methods: Systematic search was performed from inception to 18 August 2022 using PubMed, Embase, Medline, Web of Science, and Scopus. According to the Preferred Reporting Items for Systematic Reviews and Meta-analysis 2020 criteria, identification and selection of the studies was conducted.
Source: Journal of Investigative Dermatology - August 21, 2023 Category: Dermatology Authors: H. Seo, S. Kim, J. Park, S. Oh, J. Kim Source Type: research